​

Heron Therapeutics Ownership | Who Owns Heron Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Heron Therapeutics Ownership Summary


Heron Therapeutics is owned by 64.32% institutional investors, 1.06% insiders, and 34.62% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 15.84% of HRTX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.07% of its assets in Heron Therapeutics shares.

HRTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockHeron Therapeutics64.32%1.06%34.62%
SectorHealthcare Stocks 129.28%12.06%-41.34%
IndustryBiotech Stocks 181.42%11.67%-93.09%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rubric capital management lp30.05M15.84%$12.82M
Clearline capital lp11.38M6.00%$4.86M
Vanguard group9.82M5.76%$12.77M
Blackrock8.33M5.51%$29.14M
Blackrock funding, inc. /de9.83M5.16%$3.08M
Velan capital investment management lp8.75M4.62%$3.74M
Vanguard capital management7.82M4.11%$2.46M
Tejara capital6.49M3.41%$2.04M
Tang capital management6.25M3.30%$2.67M
Baker bros. advisors lp4.25M2.76%$5.36M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Velan capital investment management lp8.75M2.28%$3.74M
Tejara capital6.49M0.99%$2.04M
Clearline capital lp11.38M0.29%$4.86M
Congress park capital2.02M0.23%$860.62K
Cm management1.00M0.21%$313.50K
Ajovista19.72K0.20%$69.01K
Tang capital management6.25M0.12%$2.67M
Rubric capital management lp30.05M0.12%$12.82M
Apeiron ria370.58K0.04%$158.16K
Baker bros. advisors lp4.25M0.04%$5.36M

Top Buyers

HolderShares% AssetsChange
Baker bros. advisors lp4.25M0.04%4.25M
Vanguard group9.82M0.00%1.36M
Blackrock8.33M0.00%1.04M
Gsa capital partners llp1.04M0.03%937.83K
Aqr capital management1.55M0.00%912.27K

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp---11.19M
Orbimed advisors---9.82M
Palisade capital management, lp---6.14M
Point72 asset management---4.78M
Jw asset management140.86K0.02%-3.61M

New Positions

HolderShares% AssetsChangeValue
Baker bros. advisors lp4.25M0.04%4.25M$5.36M
Diadema partners lp458.72K0.02%458.72K$195.78K
Virtu financial283.24K0.00%283.24K$121.00K
Stonex group237.55K0.00%237.55K$90.00K
Ddfg32.90K0.00%32.90K$14.04K

Sold Out

HolderChange
Allspring global investments-1.00
Caitong asset management-1.00
Sarver vrooman wealth advisors-1.00
Toronto dominion bank-9.00
Lindbrook capital-16.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2026137-19.41%122,422,894-9.14%641.27%55-32.93%4310.26%
Jun 30, 2026168-2.89%134,895,286-14.00%711.04%80-3.61%38-11.63%
Mar 31, 2026167-4.02%156,599,4410.08%931.11%78-4.88%43-2.27%
Dec 31, 202586-50.86%47,611,662-68.81%270.28%36-54.43%18-63.27%
Sep 30, 202590-45.78%46,256,389-62.08%300.48%31-63.10%27-18.18%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF4.68M3.07%-
Vanguard Total Stock Mkt Idx Inv5.47M2.90%-
Vanguard Morn Total Stk Mkt Idx Investor5.47M2.90%-
Vanguard MStar Total Stk Mkt Idx Invest5.47M2.88%-
Palisade Small Cap Core Equity4.42M2.34%59.93K
iShares Russell 2000 ETF3.60M1.90%-
Biotech Growth Ord2.92M1.54%-
Franklin US Small Cap Growth Equity1.80M1.19%-
Vanguard Institutional Extnd Mkt Idx Tr2.10M1.11%37.42K
Fidelity Small Cap Index1.32M0.70%-305.59K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 08, 2025Rubric Capital Management LP-Buy$3.58M
Aug 08, 2025Rubric Capital Management LP-Buy-
Aug 08, 2025Rubric Capital Management LP-Buy-
Aug 08, 2025Morgan Adam-Buy$105.02K
Aug 08, 2025Morgan Adam-Buy$2.65M

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q3--
2026 Q2--
2026 Q1--
2025 Q4--

HRTX Ownership FAQ


Who Owns Heron Therapeutics?

Heron Therapeutics shareholders are primarily institutional investors at 64.32%, followed by 1.06% insiders and 34.62% retail investors. The average institutional ownership in Heron Therapeutics's industry, Biotech Stocks , is 181.42%, which Heron Therapeutics falls below.

Who owns the most shares of Heron Therapeutics?

Heron Therapeutics’s largest shareholders are Rubric capital management lp (30.05M shares, 15.84%), Clearline capital lp (11.38M shares, 6.00%), and Vanguard group (9.82M shares, 5.76%). Together, they hold 27.61% of Heron Therapeutics’s total shares outstanding.

Does Blackrock own Heron Therapeutics?

Yes, BlackRock owns 5.51% of Heron Therapeutics, totaling 8.33M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 29.14M$. In the last quarter, BlackRock increased its holdings by 1.04M shares, a 14.27% change.

Who is Heron Therapeutics’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Heron Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.28% of its assets in 8.75M Heron Therapeutics shares, valued at 3.74M$.

Who is the top mutual fund holder of Heron Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Heron Therapeutics shares, with 3.07% of its total shares outstanding invested in 4.68M Heron Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools